Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Myeloid 3Gastrointestinal 3Thoracic 1Other hematologic neoplasm 1NET 1Lymphoid 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2724Lung Neoplasms 943Small Cell Lung Carcinoma 445Neoplasms 419Colorectal Neoplasms 405Breast Neoplasms 355Melanoma 332Ovarian Neoplasms 316Neoplasm Metastasis 280Pancreatic Neoplasms 251Squamous Cell Carcinoma of Head and Neck 231Stomach Neoplasms 227Carcinoma, Renal Cell 214Triple Negative Breast Neoplasms 188Head and Neck Neoplasms 178Prostatic Neoplasms 151Esophageal Neoplasms 149Endometrial Neoplasms 145Uterine Cervical Neoplasms 138Urinary Bladder Neoplasms 132Mesothelioma 115Carcinoma 106Carcinoma, Hepatocellular 104Colonic Neoplasms 103Carcinoma, Transitional Cell 99Sarcoma 98Kidney Neoplasms 74Mesothelioma, Malignant 72Liver Neoplasms 66Cholangiocarcinoma 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Piebaldism × Thoracic × Clear all
NCT06805825 2025-09-23

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Novelty Nobility, Inc.

Phase 1 Recruiting
67 enrolled
DermatologicEndocrineGastrointestinalGenitourinaryNETSarcomaThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Carcinoma, Adenoid Cystic, Piebaldism, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡